250 related articles for article (PubMed ID: 35190110)
1. Tumor Lysis Syndrome.
Barbar T; Jaffer Sathick I
Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome: a systematic review of case series and case reports.
Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J
Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219
[TBL] [Abstract][Full Text] [Related]
3. Rasburicase in cancer-related hyperuricemia.
Rodriguez M; Campara M; Haaf C
Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
[TBL] [Abstract][Full Text] [Related]
4. Tumour lysis syndrome.
Calvo Villas JM
Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
[TBL] [Abstract][Full Text] [Related]
5. [Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare].
Burghi G; Berrutti D; Manzanares W
Med Intensiva; 2011 Apr; 35(3):170-8. PubMed ID: 21112673
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome: new challenges and recent advances.
Wilson FP; Berns JS
Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983
[TBL] [Abstract][Full Text] [Related]
7. Management of hyperuricemia with rasburicase review.
de Bont JM; Pieters R
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
[TBL] [Abstract][Full Text] [Related]
8. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
9. [Acute renal failure in patients with tumour lysis sindrome].
Poskurica M; Petrović D; Poskurica M
Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
[TBL] [Abstract][Full Text] [Related]
10. Clarifying the role of rasburicase in tumor lysis syndrome.
Sood AR; Burry LD; Cheng DK
Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
[TBL] [Abstract][Full Text] [Related]
11. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
12. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
Cortes J; Moore JO; Maziarz RT; Wetzler M; Craig M; Matous J; Luger S; Dey BR; Schiller GJ; Pham D; Abboud CN; Krishnamurthy M; Brown A; Laadem A; Seiter K
J Clin Oncol; 2010 Sep; 28(27):4207-13. PubMed ID: 20713865
[TBL] [Abstract][Full Text] [Related]
13. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Kennedy LD; Ajiboye VO
J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
[TBL] [Abstract][Full Text] [Related]
14. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
15. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
Matuszkiewicz-Rowinska J; Malyszko J
Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.
Martens KL; Khalighi PR; Li S; White AA; Silgard E; Frieze D; Estey E; Garcia DA; Hingorani S; Li A
Leuk Res; 2020 Feb; 89():106298. PubMed ID: 31945598
[TBL] [Abstract][Full Text] [Related]
17. Tumor lysis syndrome.
Jeha S
Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
[TBL] [Abstract][Full Text] [Related]
18. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
Navolanic PM; Pui CH; Larson RA; Bishop MR; Pearce TE; Cairo MS; Goldman SC; Jeha SC; Shanholtz CB; Leonard JP; McCubrey JA
Leukemia; 2003 Mar; 17(3):499-514. PubMed ID: 12646938
[TBL] [Abstract][Full Text] [Related]
19. Managing tumor lysis syndrome.
Greguska C
JAAPA; 2021 Jan; 34(1):10-13. PubMed ID: 33315730
[TBL] [Abstract][Full Text] [Related]
20. Our experience with tumor lysis syndrome treatment.
Sirelkhatim A; Sejnova D; Puskacova J; Subova Z; Kaiserova E
Bratisl Lek Listy; 2008; 109(12):560-3. PubMed ID: 19348378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
